AI4Eyes news and updates

Every material change AI Health Index has tracked at AI4Eyes: new modules, model and architecture updates, clinical evidence, regulatory status, security certifications, and integration depth. Each entry states what changed, cites its source, and carries our read on what it means for a buyer. The graded assessment of this vendor across all fifteen capability axes sits on its index profile.

Funding rounds, valuations, and awards are not product changes and are not logged here. Acquisitions appear only where there is direct product impact.

Follow this change log by RSS

Free for your reader, newsletter or automation tool. One feed covers the whole index, and every category has its own.

All feeds and terms
Impact
Type
1 entry
Showing changes for AI4Eyes only.Show the full log

November 2026

A
AI4Eyes
Nov 11, 2026
LowPartially Verified
Regulatory / FDA

AI4Eyes Medical Technologies completed FDA establishment registration and device listing for its AI eye care platform and says it can now sell the platform in the United States. This is a registration and listing, not a 510(k) clearance or De Novo authorization.

Our read

US eye care practices can now buy the platform. The release body names no device class; the page description calls it a Class I, 510(k) exempt device, which would mean no FDA premarket review of its AI claims.

Related axis: FDA and Regulatory StatusVendor announcementView source

What has changed at AI4Eyes recently?

The most recent change AI Health Index logged at AI4Eyes is dated Nov 11, 2026. AI4Eyes Medical Technologies completed FDA establishment registration and device listing for its AI eye care platform and says it can now sell the platform in the United States.